Back
ESC Premium Access

Evolution of lactate dehydrogenase levels in patients with HeartMate II, HeartWare and HeartMate 3 left ventricular assist devices during first-year follow-up

Session: Poster Session 2 - Management of patients with Left Ventricular Assist Device
Topic: Ventricular Assist Devices
Speaker: Mr Y. Yalcin (Rotterdam, NL)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Mr Yunus Can Yalcin

Rotterdam (Netherlands (The))
0 follower

11 more presentations in this session

Comparison of post-implant anticoagulation agents in left ventricular assist devices

Speaker: Doctor A. Bigeh (Phoenix, US)

Access
Abstract
Slides
Like
Thumbnail

Predictors and consequences of sustained mechanical unloading in LVAD recipients.

Speaker: Doctor J. William (Melbourne, AU)

Access
Slides
Like
Thumbnail

Frequency and patterns of implantable cardiac defibrillator therapies in patients with ventricular assist devices

Speaker: Doctor A. Gkouziouta (Athens, GR)

Access
Abstract
Like
Thumbnail

Incidence and prognosis of late-onset right ventricular failure following continuous-flow left ventricular assist device implantation as bridge to transplantation

Speaker: Doctor M. Ruiz Cano (Bad Oeynhausen, DE)

Access
Abstract
Like
Thumbnail

Subclinical persistent hemolysis may affect late renal function deterioration after HeartMateII implantation

Speaker: Doctor K. Iwasaki (Okayama, JP)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 2 - Management of patients with Left Ventricular Assist Device

Speakers: Mr Y. Yalcin, Doctor A. Bigeh, Doctor J. William, Doctor A. Gkouziouta, Doctor M. Ruiz Cano...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources